Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Board Will Add New Consumer/Patient Rep After One Member Joins Senate HELP Committee Staff

This article was originally published in The Pink Sheet Daily

Executive Summary

GAO will select replacement from previous nominations.

You may also be interested in...



Personalized Medicine Coalition Submits List Of Drug Firm Nominees For PCORI Methodology Committee

PhRMA and BIO decline to make nominations. GAO announces replacement for PCORI board.

Personalized Medicine Coalition Submits List Of Drug Firm Nominees For PCORI Methodology Committee

PhRMA and BIO decline to make nominations. GAO announces replacement for PCORI board.

PCORI Forming CER Methodology Committee

Nominations for the upcoming Patient-Centered Outcomes Research Institute’s influential methodology committee may include names previously submitted, but not selected, for the institute’s board of governors, the General Accountability Office says in a notice published in the Sept. 28 Federal Register.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071379

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel